(Q48732759)

English

Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

bipolar depression

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John I. Nurnberger

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

object named as

Amit Anand

1

0 references

author name string

Abigail D Gunn

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

Gavriel Barkay

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

Harish S Karne

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

Sanjay J Mathew

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

Samiran Ghosh

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

Bipolar Disorders

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

14

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

64-70

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

Metabotropic glutamate receptors: physiology, pharmacology, and disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Cracking the moody brain: lifting the mood with ketamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

N- methyl-D-aspartate Glutamate Receptor Antagonists and the Promise of Rapid-Acting Antidepressants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Riluzole in the treatment of mood and anxiety disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

An open-label trial of riluzole in patients with treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Riluzole augmentation for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Mechanism of action of memantine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

A double-blind, placebo-controlled study of memantine in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Antidepressant drug effects and depression severity: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Inositol as an add-on treatment for bipolar depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00971.X

21 January 2018

Identifiers

10.1111/J.1399-5618.2011.00971.X

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22329473

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48732759&oldid=2207924036"